Galapagos | Kundefordringer



Trade Debtors Endring Dato
AstraZeneca USD 14.82B 16M 2025-03
Biogen USD 1.87B 119.3M 2024-12
Genmab DKK 6.69B 381M 2024-12
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
GRIFOLS EUR 871.58M 135.79M 2024-12
Hikma Pharmaceutical USD 965M 92M 2024-06
Incyte USD 823.13M 30.02M 2025-03
Merck EUR 4.59B 127M 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
UCB EUR 1.42B 132M 2024-06
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Galapagos Kundefordringer - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.